APOA2 and familial pancreatic carcinoma: The level of apoAII-ATQ/AT, as determined by ELISA, in samples from patients with different stages of IDACP was significantly lower compared with the level in healthy controls, and this significant difference was observed even in patients in the early stages of pancreatic cancer (i.e., stages-I and -II) (Fig. 2E).